Labiotech.eu

Medical anca associated vasculitis avacopan

News and Trends 1 Dec 2021

Targeted Drugs for Rare Autoimmune Disease Hit Regulatory Milestones

New, more targeted treatments are on the horizon for the rare autoimmune disease ANCA-associated vasculitis, with a nod towards European approval for a first-in-class drug and positive phase II results from a rival treatment. In November, the Swiss firm Vifor Fresenius Medical Care Renal Pharma (VFMCRP) received a thumbs-up from the EMA for avacopan, a […]

December 1, 2021 - 4 minutesmins - By Anita Chakraverty

News and Trends 25 Nov 2021

Despite New Approvals, Covid-19 Treatments Lag Behind Vaccines

The EU recently added two drugs to its list of approved Covid-19 treatments. Yet with vaccines often in the spotlight, treatment options available to doctors remain few. Earlier this month, the European Commission gave its stamp of approval to two antibody treatments for Covid-19: regdanvimab from the South Korean firm Celltrion Healthcare, and a blend […]

November 25, 2021 - 6 minutesmins - By Victor Kotsev

cell therapy manufacturing reprogramming synbio

News and Trends 22 Nov 2021

Investors Flock to Startups Reprogramming Cell Therapies

Painstaking and expensive procedures are required to produce human cells for use in research and cell therapies. Investors are seeking stakes in cell reprogramming startups that can free up the bottleneck, such as Mogrify, bit.bio, and Asgard Therapeutics. The concept of cell reprogramming — converting one type of cell into another — has been hot […]

November 22, 2021 - 7 minutesmins - By Jonathan Smith

Industrial biotech sustainability environment

News and Trends 18 Nov 2021

Sustainability in Focus as Two VCs Build Industrial Biotech Funds

As this month’s COP26 United Nations climate summit highlighted the climate change emergency, venture capital fundraises from Sofinnova and the European Circular Bioeconomy Fund have led the push for industrial biotechnology to further shift the global economy away from fossil fuels. Yesterday, the venture capital (VC) firm Sofinnova Partners raised €150M for an early-stage environmental […]

November 18, 2021 - 4 minutesmins - By Anita Chakraverty

treatments, biotech, genes, biomanufacturing, infographic

Infographics by 15 Nov 2021

Gene therapy: Making Rare Disease Therapies Less Rare

While individually uncommon, rare diseases collectively impact the lives of over 300 million people worldwide. Many rare conditions are chronic, progressive, and life-threatening with limited treatment options available. Advances in gene therapy provide hope to actual cures and could revolutionize treatment prospects for patients with rare genetic diseases. This infographic shows how we can unlock […]

November 15, 2021 - 2 minutesmins - By External Contributor

News and Trends 12 Nov 2021

Big Pharma Strikes Megadeals In Targeted Protein Degradation

With many targeted protein degraders hitting the clinic, lucrative collaborations and acquisitions are being signed between biotech startups and big pharma in this upcoming area. Novartis, Pfizer, and Bayer have all negotiated billion Euro deals this year with smaller biotechs including Dunad Therapeutics, Arvinas, and Vividion Therapeutics. The big pharma companies aim to gain a […]

November 12, 2021 - 5 minutesmins - By Anita Chakraverty

News and Trends 10 Nov 2021

Evotec IPO Hints At Stabilizing Investor Interest In Biotech Stocks

German life sciences heavyweight Evotec raised around €376M ($435M) in its US debut on the Nasdaq last week, fueling tentative hopes of renewed investor interest in biotech stocks after a rollercoaster year. The company downsized its initial IPO target of around €500M ($576M) by offering fewer shares than initially planned. This is widely seen as […]

November 10, 2021 - 4 minutesmins - By Victor Kotsev

Opinion 10 Nov 2021

Automation Can Solve Diversity Issues in Clinical Trial Recruitment

How can we make clinical trial recruitment more reflective of the real world? Technology is coming to the rescue. The quest for diversity in clinical trials goes to the heart of patient care. Why are some demographic groups over-represented in studies when others are more difficult to recruit? Studies that fail to reflect patient demographics […]

November 10, 2021 - 6 minutesmins - By External Contributor

In Depth 8 Nov 2021

Blockchain Makes Biotech Supply Chains Traceable

Blockchain technology can be used to reliably trace entire supply chains, preventing counterfeit drugs and foods from making their way to consumers. Supply chains are long, often spanning multiple continents, complex, and dotted with blind spots. These opaque gaps leave room for unethical agents to interfere with the supply chain. If you were running a […]

November 8, 2021 - 6 minutesmins - By Sachin Rawat

News and Trends 4 Nov 2021

Skilled Labor Shortages Impact Cell And Gene Therapy Manufacturing

Despite vast amounts of funding entering the cell and gene therapy field, the manufacture of these therapies is held back by skill shortages. Increasing training programs and automation could form the solution. The cell and gene therapy fields enjoyed their best-ever funding yield in the first half of 2021, with €12.2B ($14.1B) netted globally. However, […]

November 4, 2021 - 5 minutesmins - By Anita Chakraverty

News and Trends 2 Nov 2021

The Top European Biotech Investment Rounds in October

DNA manufacturing was a hot topic in biotech investments in October, with immuno-oncology and insect protein also drawing big investor excitement. After the huge biotech investment rounds that took place in September, October was a quieter month for private European and Israeli life sciences firms. Collectively, they raised €555.6M in 37 deals. This was less […]

November 2, 2021 - 5 minutesmins - By Jonathan Smith

Expert Advice 1 Nov 2021

“The Board of Directors Should Let the CEO Run the Company”

The relationship between the board and the CEO can be essential to the success of a life sciences company. Drawing from his experience at both sides, Alan Levy shares his advice on how to make that relationship work. Once known as the person who introduced portable defibrillators on the market in the 1990s, Alan Levy […]

November 1, 2021 - 5 minutesmins - By Victor Kotsev

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Targeted Drugs for Rare Autoimmune Disease Hit Regulatory Milestones

Despite New Approvals, Covid-19 Treatments Lag Behind Vaccines

Investors Flock to Startups Reprogramming Cell Therapies

Sustainability in Focus as Two VCs Build Industrial Biotech Funds

Gene therapy: Making Rare Disease Therapies Less Rare

Big Pharma Strikes Megadeals In Targeted Protein Degradation

Evotec IPO Hints At Stabilizing Investor Interest In Biotech Stocks

Automation Can Solve Diversity Issues in Clinical Trial Recruitment

Blockchain Makes Biotech Supply Chains Traceable

Skilled Labor Shortages Impact Cell And Gene Therapy Manufacturing

The Top European Biotech Investment Rounds in October

“The Board of Directors Should Let the CEO Run the Company”

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!